BCM
PRAH

BlueMar Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

BlueMar Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,000
Closed -$827K – 77
2016
Q4 		$827K Buy
+15,000
New +$823K 0.44% 58

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlueMar Capital Management's PRAH Position: Q1 2017 in Review

BlueMar Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2017, closing a stake of 15,000 shares — an estimated $827K sold.

BlueMar Capital Management first reported a position in PRAH in Q4 2016 and held it in 1 quarter. The position peaked at $827K in Q4 2016. 229 funds tracked by Wall St. Rank hold PRAH as of Q1 2017.

  • BlueMar Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2017 after selling out during the quarter.
  • BlueMar Capital Management sold 15,000 PRA Health Sciences, Inc. shares in Q1 2017, an estimated $827K.
  • BlueMar Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 1 quarter.
  • BlueMar Capital Management's PRA Health Sciences, Inc. position peaked at $827K in Q4 2016.
  • 229 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2017.

Based on BlueMar Capital Management's 13F filing for Q1 2017, filed 15 May 2017.